These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2422095)

  • 21. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits.
    Weber AA; Hohlfeld T; Strobach H; Schrör K
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):332-8. PubMed ID: 7679170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preservation of platelet function in cryopreserved platelet concentrates with prostacyclin.
    Johnson EJ; Mackie IJ; Machin SJ; Brozović B
    Clin Lab Haematol; 1984; 6(2):141-4. PubMed ID: 6207975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months.
    Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF
    Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
    Wilson AP; Efthimiou J; Betteridge DJ
    Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological actions of prostacyclin and its pharmacological use in platelet studies.
    Moncada S; Whittle BJ
    Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
    Skuballa W; Vorbrüggen H
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():299-305. PubMed ID: 6189381
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis.
    Watanabe T; Kishi Y; Numano F; Isobe M
    Thromb Res; 2001 Oct; 104(2):77-83. PubMed ID: 11672751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
    Data JL; Molony BA; Meinzinger MM; Gorman RR
    Circulation; 1981 Jul; 64(1):4-12. PubMed ID: 6263515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrillatory action of the stable orally active prostacyclin analogues iloprost and ZK 96 480 in rats after coronary artery ligation.
    Müller B; Maass B; Stürzebecher S; Skuballa W
    Biomed Biochim Acta; 1984; 43(8-9):S175-8. PubMed ID: 6083785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of aspirin infusions on platelet function in humans.
    Wilson KM; Siebert DM; Duncan EM; Somogyi AA; Lloyd JV; Bochner F
    Clin Sci (Lond); 1990 Jul; 79(1):37-42. PubMed ID: 2167788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients.
    Cohen H; Neild GH; Patel R; Mackie IJ; Machin SJ
    Thromb Res; 1988 Jan; 49(1):91-101. PubMed ID: 2450411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
    Addonizio VP; Fisher CA; Kappa JR; Ellison N
    Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.